Nora Henrikson, PhD, MPH, conducts research that seeks to improve the lives of people with cancer and their families. Her current projects include interventions to mitigate cancer-related financial hardship and to improve communication with families about genetic risk. In addition, she leads KPWA’s participation in the Kaiser Permanente Evidence-Based Practice Center.
Dr. Henrikson joined Kaiser Permanente Washington Health Research Institute as a research associate in 2010.
Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication
Genetic testing for cancer risk, cancer-related financial hardship
Social, ethical, and policy implications of genomics and precision health
Henrikson NB, Davison BJ, Berry DL. Measuring decisional control preferences in men newly diagnosed with prostate cancer. J Psychosoc Oncol. 2011;29(6):606-18. PubMed
Grossman D, Fishman P, Beck A, Reid R, Ritzwoller D, Martin D, Henrikson N, Hubbard R, Scrol A. Quasi-experimental evaluation of a value-based health plan design among healthcare employees. Clin Med Res. 2011;9(3-4):173-4.
Standaert CJ, Friedly J, Erwin MW, Lee MJ, Rechtine G, Henrikson NB, Norvell DC. Comparative effectiveness of exercise, acupuncture, and spinal manipulation for low back pain. Spine. 2011;36(21 Suppl):S120-30. PubMed
Henrikson NB, Ellis WJ, Berry DL. "It's not like I can change my mind later": reversibility and decision timing in prostate cancer treatment decision-making. Patient Educ Couns. Nov;77(2):302-7. Epub 2009 Apr 21.
Henrikson NB, Bowen D, Burke W. Does genomic risk information motivate people to change their behavior? Genome Med. 2009 Apr 2;1(4):37.
James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM. Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet. 2008;11:241-49.
Henrikson NB, Harris JN, Bowen D. Predictors of recruitment method to a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1387-92.
Henrikson NB, Burke W, Veenstra DL. Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J. 2008 Apr;8(2):85-9. PubMed
Battuello K, Henrikson NB. Genetics and public health: past, present, and future In: Battuello K, Kuslzer P, O’Connor S, editors. Genetic technologies and the law: cases and materials. Carolina Academic Press; 2006.
Battuello K, Henrikson NB. Access to and disclosure of genetic information: rights, duties and liabilities. In: Battuello K, Kuslzer P, O’Connor S, editors. Genetic technologies and the law: cases and materials. Carolina Academic Press; 2006.
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.
Avalere podcast, Feb. 22, 2019